Tubulis Gmbh
Clinical trials sponsored by Tubulis Gmbh, explained in plain language.
-
New smart drug targets Hard-to-Treat ovarian and lung cancers
Disease control Recruiting nowThis study tests a new drug called TUB-040 in people with ovarian cancer that no longer responds to platinum chemotherapy, or with a type of lung cancer that has returned. TUB-040 is designed to deliver a cancer-killing agent directly to tumor cells that have a specific marker (N…
Phase: PHASE1, PHASE2 • Sponsor: Tubulis GmbH • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New drug TUB-030 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase trial tests a new drug, TUB-030, in adults with advanced solid tumors like head and neck, lung, breast, or colorectal cancer. The main goals are to find a safe dose and check for side effects. Researchers will also compare different doses in people with head and …
Phase: PHASE1, PHASE2 • Sponsor: Tubulis GmbH • Aim: Disease control
Last updated May 18, 2026 12:02 UTC